Chemistry: molecular biology and microbiology – Animal cell – per se ; composition thereof; process of...
Patent
1994-11-28
1997-07-08
Guzo, David
Chemistry: molecular biology and microbiology
Animal cell, per se ; composition thereof; process of...
4353201, 435366, 435372, 435352, 435350, 435364, 435358, 435357, C12N 516, C12N 1586
Patent
active
056460325
ABSTRACT:
The present invention relates to the preparation of novel vector systems which are generated by in-vitro recombination, using gene technology, of nucleic acids from foamy virus species and of exogenous nucleic acid, and are produced by suitable host cells or by recombinantly altered packaging cell lines. The recombinant preparation of particularly suitable packaging cell lines is likewise a constituent of this invention. The invention is distinguished by the safe and efficient transfer by foamy virus vectors of therapeutic and other genes into eukaryotic cells.
REFERENCES:
Rethwilm et al. "Transacting Transcriptional Activation of Human Spumaretrovirus LTR in Infected Cells", Virology, vol. 175, 1990, pp. 568-571.
Netzer et al. "Identification of Pol-Related Gene Products of Human Foamy Virus", Virology, vol. 192, 1993, pp. 336-338.
Bothe et al. "Progressive Encephalopathy and Myopathy in Transgenic Mice Expressing Human Foamy Virus Genes", Science, vol. 253, 2 Aug. 1991, pp. 555-557.
D. Jolly, Cancer Gene Therapy, 1: 51-64 (1994).
J.M. Coffin, "Retroviridae and their Replication", in Virology, 2nd ed., pp. 1437-1440.
J.J. Hooks et al., Bacteriol. Rev., 39: 169-185 (1975).
J.J. Hooks et al., "Spumavirinae: Foamy Virus Group Infections: Comparative Aspects and Diagnosis", in Comparative Diagnosis of Viral Diseases, 4: 599-618 (1981).
D. Neumann-Haefelin et al., Intervirology, 35: 196-207 (1993).
P. Loh, "Spumaviruses", in The Retroviridae, 2: 361, Plenum Press, New York, 1993.
M. Schweizer et al., AIDS Research and Human Retroviruses, 10: 601-605 (1994).
M. Schweizer et al., AIDS Research and Human Retroviruses, 11: 161-170 (1995).
R. Weiss, Nature, 333: 497-498 (1988).
M. Schmidt et al., Virology, 210: 000-000 (in press).
O. Erlwein et al. et al., Virology, 196: 256-268 (1993).
G. Braunach et al., J. Virology, 67: 5411-5418 (1993).
L. Hong et al., Virus Research, 30: 89-95 (1993).
A. D. Miller et al., PNAS, 80: 4709-4713 (1983).
A. Kasid et al, PNAS, 87:473-477 (1990).
J. M. Wilson et al., Science, 248: 1413-1416 (1990).
S. A. Rosenberg et al., Human Gene Therapy, 3: 57-73 (1992).
B. Gansbacher et al., Human Gene Therapy, 3: 691-703 (1992).
B. Gansbacher et al., Human Gene Therapy, 3: 677-690 (1992).
M. T. Loetz et al., Human Gene Therapy, 5: 41-55 (1994).
H. Fakhrai et al., Human Gene Therapy, 6: 591-601 (1995).
Genzyme Diagnotics Catalog (1994), pp. 1, 43, 59.
J. Larrick et al., Gene Therapy: Application of Molecular Biology, Elsevier, New York, 1991, pp. 77-84.
A. D. Miller et al., Biotechniques, 7: 980-990 (1989).
R. M. Flugel et al., Embo J. 6, 2077-2084 (1987).
B. Maurer et al., J. Virol. 62, 1590-1597 (1988).
A. Rethwilm et al., Nucleic Acids Res. 18, 733-738 (1990).
A. D. Miller et al., Biotechniques 7, 980-990 (1989).
A. Rethwilm et al., Gene 59, 19-28 (1987).
A. Rethwilm et al. Nucleic Acids Research, vol. 18, No. 4, 1990, pp. 733-738.
Vile et al. Virology, vol. 189, No. 2, Aug. 1992, pp. 786-791.
Maurer et al. Journal of Virology, vol. 65, No. 11, Nov. 1991, pp. 6353-6357.
Lee et al. Journal of Virology, vol. 67, No. 4, Apr. 1993, pp. 2317-2326.
Rethwilm Axel
ter Meulen Volker
Bayer Aktiengesellschaft
Guzo David
LandOfFree
Recombinant foamy virus vectors for medicinal, and diagnostic us does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Recombinant foamy virus vectors for medicinal, and diagnostic us, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Recombinant foamy virus vectors for medicinal, and diagnostic us will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2408380